ArticleBlood advances2018
An inhibitor of proteasome β2 sites sensitizes myeloma cells to immunoproteasome inhibitors.
Sondra Downey-Kopyscinski et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papercites it